Platelet-derived growth factor (PDGF) in vitro stimulates DNA synthesis and chemotaxis of fibroblasts and smooth muscle cells and stimulates collagen, glycosaminoglycan, and collagenase production by fibroblasts. These in vitro properties suggest that PDGF, delivered by platelets to the site of injury in vivo, may play an important role in the initiation of the wound repair process. Studies presented here show that the addition of pure PDGF to a wound site involving the epidermis and dermis has little effect on the morphology or biochemistry of the healing wound. In contrast, the addition of partially purified PDGF resulted in significant dose-dependent increases in the width of the newly synthesized connective tissue and epidermal layers. Autoradiography using [3H]thymidine revealed increased numbers of labeled cells in the new connective tissue and epithelial layers. Furthermore, addition of partially purified PDGF resulted in significant increases in the rate of protein and DNA synthesis and the total content of these components in biopsies taken from the wound site. Similar effects were obtained when insulin-like growth factor I was added in combination with pure PDGF. This combination of factors caused a 2.4-fold increase in the width of the newly formed connective tissue layer and a 95% increase in epidermal thickness compared with controls. Insulin-like growth factor I alone caused no significant morphologic changes. Epidermal growth factor alone or in combination with PDGF resulted in a thickening only of the epidermis. These results indicate that the synergistic actions of other factors with PDGF are important in the modulation of the wound healing process.
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Platelet-derived growth factor (PDGF) is a cationic, heatstable protein stored in the a granules of circulating platelets and is released from platelets into the serum during blood clotting. PDGF is the major human serum polypeptide growth factor and is a potent mitogen for cells of mesenchymal origin, such as fibroblasts and arterial smooth muscle cells. PDGF stimulates many metabolic processes, including general protein and collagen synthesis, collagenase activity, and chemotaxis of fibroblasts and of smooth muscle cells. Furthermore, PDGF has been shown to stimulate the production of IGF-I (insulin-like growth factor I or somatomedin C) in cultured human fibroblasts and porcine aortic smooth muscle cells (for recent reviews, see refs. 1-3). These in vitro properties suggest that PDGF, delivered from platelets at the site of injury in vivo, may play an important role in the initiation of the repair process of wounds. Subsequently, monocytes, macrophages (4), and injured endothelial cells (5) may provide a local source of PDGF-like molecules for continuation of the repair process.
At present, reports on the in vivo effects of PDGF on wound healing are contradictory. Normal skin wound healing in hamsters was not accelerated by low levels of PDGF (6) .
In other studies PDGF increased collagen formation when added to wire-mesh chambers implanted subcutaneously in the backs of rats (7) .
In addition to PDGF, other growth factors, such as epidermal growth factor (EGF), transforming growth factors a and f, and IGF-I, have been proposed to play important roles in the repair of various tissues (8) (9) (10) (11) (12) (13) . In this report we present findings on the effect of both partially purified PDGF and purified PDGF alone and in combination with EGF and IGF-I on wound healing in young White Yorkshire pigs, one of the two standard models for evaluating agents that may effect the healing of skin injuries.
MATERIALS AND METHODS
Surgical Wounding. The wound-healing model used in these studies is a modification of that described by Eaglstein and co-workers (14) . Young White Yorkshire pigs (10-15 kg) were anesthetized using ketamine (30 mg/kg), xylazine (2 mg/kg), and atropine (0.05 mg/kg). The back and thoracic areas were clipped, shaved, and washed using mild soap and water, and the area to be wounded was disinfected with 70% (vol/vol) alcohol. Rectangular wounds (initially 8 x 12 mm and subsequently 10 x 20 mm) were surgically induced at a depth of 0.5 mm using a modified Castroviejo electrokeratome (Storz, St. Louis, MO; modified by Brownells, Montezuma, IA). This procedure completely removed the epidermis and a zone of superficial dermis, but spared the hair follicles (comparable to a second-degree burn injury). The individual wounds were separated by at least 15 mm of unwounded skin. A preparation of partially purified PDGF (ppPDGF) (PDGF, Inc.) was also tested, which was obtained from a soluble, heat-treated human platelet fraction by chromatographic separation on CM-Sephadex (15, 16) . One nanogram equivalent of ppPDGF is equal in biologic activity to 1 ng of purified PDGF as judged by the uptake of [3H]thymidine by BALB/c 3T3 cells (16) . ppPDGF was applied directly to Abbreviations: PDGF, platelet-derived growth factor; pp, partially purified; EGF, epidermal growth factor; IGF-I, insulin-like growth factor.
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Clearance of "2I-Labeled PDGF. Clearance of pure PDGF from the wound site was estimated by application of 15 ng of 1251-labeled PDGF (17) (30,000 dpm/ng; PDGF, Inc.) in 20 Atl of diluent containing 500 ng of unlabeled PDGF. AT 4, 8, 12, 24, 48 , and 72 hr following treatment, 1.5-mm-deep biopsies were obtained as described below, and total residual 1251 was measured. The biopsies were homogenized (Polytron; Brinkman Instruments), and 1251-labeled PDGF was extracted in 5 ml of 75% (vol/vol) ethanol and 6% (vol/vol) acetic acid at 40C, overnight. The homogenates were centrifuged at 40C, and the precipitate reextracted twice with cold acetic acid/ethanol. The supernatant fluids were combined, dialized, lyophilized, and reconstituted in 0.5 ml of 0.5 M NaCi. The solution was diluted to 2 ml with 0.02 M sodium phosphate-buffered saline (pH 7.4) containing 0.05% Tween 20 and 0.1% human serum albumin. Aliquots were subjected to immunoprecipitation with excess rabbit PDGF antisera.
The 1251-labeled PDGF-antiserum complexes were precipitated by the addition of a goat anti-rabbit antiserum. The precipitate and supernatant were separated by centrifugation. The immunoprecipitable radioactivity was considered to represent intact PDGF, and radioactivity in the supernatant fluid was considered to be degradation products.
Biopsy Technique. Wounds were biopsied on days 1-7 and day 10 . Biopsies for histologic evaluation were taken as a wedge -3 mm deep through the center ofthe wound and fixed in 10%o (vol/vol) formalin. Specimens were taken from separate wounds for biochemical analysis and autoradiography using an electrokeratome set at a depth of 1.5 mm with 1-2 mm of normal unwounded skin surrounding the biopsy. The latter specimens were trimmed to 1 cm in width. From the center of the trimmed wound biopsy, standardized 1.5-mm-wide specimens were then obtained using a gel cutter with the result that all specimens had final dimensions of 1.5 x 10 x 1.5 mm. Three specimens were collected per wound for individual biochemical analysis, and two were for autoradiography. Specimens for in vitro metabolic labeling were placed in cold Eagle's minimum essential media (MEM) supplemented with 10%o (vol/vol) fetal bovine serum.
In Vitro Metabolic Labeling. Biopsy specimens for biochemical analysis were transferred to individual tubes containing 0.3 ml of MEM plus 10% (vol/vol) fetal bovine serum, [3H]thymidine at 15 uCi/ml, and [14C]leucine at 5 ,uCi/ml (1 Ci = 37 GBq). Samples were incubated for 1 hr at 37°C (18) , at which time the medium was removed, and tissue metabolism was stopped by addition of 0.5 ml of cold 5% (vol/vol) perchloric acid. Subsequently, specimens were finely minced and washed three times with cold 5% (vol/vol) perchloric acid. The resulting precipitate was resuspended in 0.5 ml of concentrated ammonium hydroxide and sonicated. Samples were then incubated in sealed tubes at 45°C for [16] [17] [18] [19] [20] [21] [22] [23] [24] hr, after which they were resonicated, and the radioactivity of 50-Al aliquots was measured. Biopsy specimens for autoradiography also were incubated in 0.3 ml ofMEM, 10% (vol/vol) fetal bovine serum, and [3H]thymidine at 15 ,Ci/ml for 1 hr. Incubation was stopped by washing the samples with 10% (vol/vol) formalin. The samples were stored in this fixative until histochemical processing.
DNA and Protein Determination. DNA content was measured by a modification of the method of Labarca and Paigen (19) . A 50-,ul aliquot of tissue extract described above was added to 400 ,ul of 1 M Na2HPO4/2 M NaCl, pH 7.0. Samples were adjusted to pH 7.4 with HCl and to a final volume of 500 p.1 with buffer. The sample was then added to 2.5 ml of Hoechst dye 33258 (1.14 pug/ml) in 0.05 M sodium phosphate, pH 7.4/2 M NaCl. Fluorescence was induced at excitation wave length of 352 nm, and emission was measured at 454 nm. Calf thymus DNA prepared by identical treatment was used for standardization. Protein content of the tissue extract was measured by the Bradford method (20) with bovine serum albumin and type 1 collagen as standards.
Morphometric Analysis. Four-micrometer paraffin-embedded sections were made perpendicular to the skin surface and stained using filtered Harris hematoxylin and alcoholic eosin. The specimens were coded for microscopic analysis and scored by two investigators. From seven to nine lines perpendicular to the skin surface were marked arbitrarily every 1-2 mm along the sections, and the widths of the epithelial and new connective tissue layers were measured using a grid placed within the ocular. This value was then converted into micrometers using a calibration ruler viewed under the same conditions. Autoradiograms (exposed for 1-2 weeks with NTB-2 emulsion, Kodak) were scored at similarly distributed points by counting the number of labeled nuclei (5 grains or more per cell) and the total number of nuclei in the same field. Cell density was scored by counting the total number of nuclei within a grid box.
Statistical Analysis. 125I-labeled PDGF applied to wounds was cleared rapidly during the first 4-8 hr, such that 22.5% of the total radioactivity remained 12 hr after application (Fig. 1) . The rate ofloss then slowed, and from 24 to 72 hr the levels remained nearly constant with 14.3% of the original radioactivity remaining at 72 hr. As seen in Fig. 1, at 4 hr 65% of the remaining 125I was resistant to extraction with this percentage increasing to 90% by 72 hr.
At 4 hr after addition of '251-labeled PDGF, 61% of the total extractable radioactivity recovered from wounds was immunoprecipitable with antiserum to PDGF (compared to 78% from the original PDGF preparation, Fig. 1 Fig. 2 A and B) . This increased cell density appeared to be predominantly due to an increase in fibroblasts without obvious differences in leukocyte infiltration.
When 500 ng of pure PDGF was applied to wounds in combination with an equal amount of EGF, a 44% increase in the width of the new epidermis (P < 0.05) with enlarged basal keratinocytes and a thicker layer of keratinized tissue resulted (Fig. 2C) . Increased length of epithelial rete pegs (i.e., extensions of the epithelial cell layer into the connective tissue layer) was also evident. These epithelial effects were similar to those observed when EGF alone was added. The new connective tissue layer resembled that observed when PDGF alone was added.
IGF-I alone caused no significant morphological changes. However, wounds treated with IGF-I and purified PDGF had a more marked connective tissue response (Fig. 2D ) than wounds treated with PDGF alone. At day 7, the layer of new connective tissue was 2.5-fold wider than that observed in controls and 2.2-fold greater than that measured when PDGF was applied alone or with EGF (both P < 0.05). This increased width was due to an increase in cell population and greater extracellular spaces. These wounds also exhibited epithelial changes with a thickened epidermis (95 ± 7% thicker, P < 0.001) and longer epithelial projections when compared to controls, PDGF alone, or IGF-I alone.
Effect of ppPDGF on Wound Healing. Histologic evaluation of day-4 wounds (8 x 12 x 0.5 mm) treated with 500 ng equivalents of ppPDGF in diluent revealed a large increase in cellular and extracellular components of the new connective tissue of treated wounds as compared to controls. Morphometry showed the mean thickness of the new connective tissue layer of the treated wounds to be 2.6-fold greater (P < 0.05) than that of control wounds (Fig. 3A) . Epithelium projected extensively into the new connective tissue layer and had a slight increase in average thickness. At 6 days the new connective tissue layer was 5-fold larger than in controls ppPDGF was also applied topically in a gel suspension at a dose of 500 ng per wound with similar results (Fig. 3B) (P < 0.05). The mean width ofthe new connective tissue layer in the wounds receiving the gel plus ppPDGF was 3.2-fold greater than wounds that received the gel alone (P < 0.0001). By 6 days, the mean epidermal thickness for wounds receiving ppPDGF was also greater than that observed in wounds receiving the gel alone. The new connective tissue layer in treated wounds was 3.0-fold (P < 0.001) greater than in untreated wounds.
Dose-Response Effect of ppPDGF. ppPDGF (800 ng, 400 ng, and 200 ng) was added as a suspension in gel to 10 x 20 x 0.5-mm wounds. The effects of ppPDGF in these larger wounds were apparent at all concentrations used at day 6 and increased until day 10. As shown in Fig. 4 , increased concentrations of ppPDGF caused progressive increases in the new connective tissue layer and the epithelial thickness. These effects at 10 days in the 10 x 20 x 0.5-mm wounds treated with 400 ng of ppPDGF were similar to those observed at day 6 in the 8 x 12 x 0.5-mm wounds treated with 500 ng of ppPDGF. The wounds receiving the gel and 400 ng equivalents of ppPDGF had 2.7 times the mean epithelial thickness of the wounds treated with the gel alone (P < 0.001). The new connective tissue layer in these treated wounds was 2.9 times greater than that observed in control wounds (P < 0.0001).
Autoradiographic Analysis. When 500 ng of gel-suspended ppPDGF was applied, the percentage of epithelial cells labeled was 2.1 times greater than in controls on day 4 (30.0 ± 6.2% vs. 14.1 ± 6.1%, respectively; P < 0.05). There was also a 2.9-fold greater number of new connective tissue cells labeled in treated wounds compared to untreated wounds (4.3 ± 1.4% vs. 1.5 ± 0.8%, respectively; P < 0.01).
At 6 days following wounding, the percentage of all cells labeled decreased, with epithelial cells still comprising 85% of all cells labeled. At this time there was not a significant difference in the number of epithelial cells labeled in control and treated wounds. However, treated wounds had 3.1-fold more new connective tissue cells labeled than controls (5.9 ± 3.9% labeled cells in treated wounds vs. 1.9 ± 1.2% labeled cells in control wounds; P < 0.05). DNA and Total Protein Content. Wounds treated with 500 ng equivalents of ppPDGF had significantly greater DNA content on days 3-10 than did controls (Table 1) . On average the ppPDGF-treated wounds at day 3 had 76% more DNA per mm3 (P < 0.05) than control wounds and 74% (P < 0.05) and 27% (P < 0.05) more DNA at days 6 and 10, respectively. Acid-precipitable protein was increased in ppPDGF-treated wounds at 3 and 6 days following wounding by 19% and 78%, respectively (both P < 0.05), compared to controls. By day 10 there was only a 6% (P > 0.05) increase in acid- Total DNA and noncollagenous protein content of 8 x 12 x 0.5-mm wounds treated with 500 ng of ppPDGF in methyl cellulose gel. Data was obtained from 1.5 x 10 x 1.5-mm biopsies taken from healing wounds at days 3, 6, and 10. (Mean ± 1 SD; n = 27.) *P < 0.05. precipitable protein in treated wounds (Table 1 ). However, it should be noted that standard curves using type 1 collagen indicated that the Bradford method of protein determination used detected only 15% of collagenous proteins.
DISCUSSION
The addition of purified PDGF to wounds involving the epidermis and dermis results in increased cell density of the loose subepithelial connective tissue layer but causes little or no increased production of extracellular connective tissue components and no increased growth of the epithelial cell layer. Thus as judged by this model addition of pure PDGF alone appears to be of limited value in accelerating normal wound repair.
In contrast, the addition of ppPDGF in equivalent doses resulted in a large increase in new connective tissue formation. Not only did incorporation of [3H]thymidine and total DNA content increase, but there was also a large increase in protein synthesis and in the production of extracellular connective tissue matrix, as judged by the increased thickness of the newly formed connective tissue layer and total protein assays.
Although more variable, the ppPDGF also produced an increase in cell proliferation in the epithelial layer resulting in a thicker epidermis with extensive rete pegs. These initial growth characteristics seen in treated wounds resemble those seen in psoriatic lesions, which also have elongated rete pegs. The epithelial effects caused by ppPDGF were, however, transitory, and after 6 weeks no evidence of a psioratic appearance remained nor was there scar formation. In fact, no histologic differences could be detected between pp-PDGF-treated and control wounds after 6 weeks.
Hebda and Eaglstein (21) reported that platelets contain growth factors that stimulate epidermal cell outgrowth in skin explants. One such factor was reported to be heat stable and partitioned into the >30-kDa fraction. It is, therefore, possible that this factor may be at least partially responsible for the epithelial effects caused by the ppPDGF.
Since the exact nature of the additional factor(s) in pp-PDGF necessary for the described effects is as yet unknown, pure PDGF was combined with other known growth factors to determine if these combinations could produce effects similar to those produced by ppPDGF. The addition of EGF or IGF-I to pure PDGF generally was not able to reproduce all the effects observed with ppPDGF. However, the histologic appearance ofwounds treated with the combination of pure IGF-I and PDGF did approximate that of wounds treated with ppPDGF. The wounds receiving the combination of IGF-I and PDGF had significant epithelial extensions present, and the width of the new connective tissue layer was greater than that observed when using pure PDGF or IGF-I alone, thus indicating the synergistic effects of these factors in vivo. This coordinate in vivo effect of PDGF and IGF-I is consistent with in vitro data that demonstrated the need of both factors for the progression of 3T3 fibroblasts into the S phase of the cell cycle (13) .
Wound healing is a complex process involving cell-cell and cell-macromolecular interactions. The model system described here represents a healing of the epidermis and dermis and would be analogous to external traumatic injuries, burns, and disease states involving the integument. The biochemical data presented demonstrate an increase in DNA and protein synthesis and content in wounds treated with ppPDGF. The histologic data reflect this increased activity in wounds treated with either ppPDGF or a combination of pure PDGF and IGF-I by showing visually a hyperplasia of both new connective tissue and epithelial layers. 
